1. Home
  2. GPCR vs HTGC Comparison

GPCR vs HTGC Comparison

Compare GPCR & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$44.81

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Logo Hercules Capital Inc.

HTGC

Hercules Capital Inc.

HOLD

Current Price

$15.45

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPCR
HTGC
Founded
2016
2003
Country
United States
United States
Employees
N/A
50
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GPCR
HTGC
Price
$44.81
$15.45
Analyst Decision
Strong Buy
Buy
Analyst Count
12
7
Target Price
$103.17
$18.86
AVG Volume (30 Days)
701.2K
1.4M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
12.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.18
Revenue Next Year
N/A
$5.24
P/E Ratio
N/A
$8.61
Revenue Growth
N/A
N/A
52 Week Low
$15.80
$13.70
52 Week High
$94.90
$19.67

Technical Indicators

Market Signals
Indicator
GPCR
HTGC
Relative Strength Index (RSI) 61.56 49.23
Support Level $42.72 $15.22
Resistance Level $57.23 $15.96
Average True Range (ATR) 2.20 0.28
MACD 0.91 0.01
Stochastic Oscillator 74.71 60.87

Price Performance

Historical Comparison
GPCR
HTGC

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About HTGC Hercules Capital Inc.

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.

Share on Social Networks: